Safety & Interactions

Itraconazole has a well-documented conventional medical safety history, but cancer use still needs proper review because it is a real drug with real pharmacology.

General tolerability

Common side effects can include:

• nausea

• diarrhoea

• abdominal pain

• rash

• headache

More serious but less common concerns include:

• liver toxicity

• heart-failure risk in susceptible patients

Practical cautions

• active liver disease deserves caution

• drug interaction review is essential

• cardiac history matters, especially where heart-failure risk is relevant

• combination use in active oncology care should always be supervised

How to interpret interaction evidence

Cell and laboratory findings can identify a possible interaction. They do not confirm the same effect occurs in people.

Read interaction claims alongside human pharmacokinetic and clinical evidence. See Drug Interaction Evidence and CYP Enzymes for the evidence hierarchy and practical questions to ask.

Clinical positioning

Itraconazole is not a casual supplement-style adjunct. It is a repurposed drug, which means it deserves the same respect as any other active medication in a cancer plan.

Key References

Repurposing itraconazole for the treatment of cancer
https://pmc.ncbi.nlm.nih.gov/articles/PMC6769799/

Itraconazole — Wikipedia
https://en.wikipedia.org/wiki/Itraconazole